372 related articles for article (PubMed ID: 8606319)
1. Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.
Brundage MD; Mackillop WJ
J Clin Epidemiol; 1996 Feb; 49(2):183-92. PubMed ID: 8606319
[TBL] [Abstract][Full Text] [Related]
2. Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studies.
Choy H; Gerber DE; Bradley JD; Iyengar P; Monberg M; Treat J; Govindan R; Koustensis A; Barker S; Obasaju C
Lung Cancer; 2015 Mar; 87(3):232-40. PubMed ID: 25650301
[TBL] [Abstract][Full Text] [Related]
3. Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
Belani CP; Ramanathan RK
Chest; 1998 Jan; 113(1 Suppl):53S-60S. PubMed ID: 9438691
[TBL] [Abstract][Full Text] [Related]
4. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
5. Reporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.
Ghimire S; Kyung E; Kim E
Lung; 2013 Aug; 191(4):313-9. PubMed ID: 23715997
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy of non-small cell lung cancers.
Juretic A; Sobat H; Samija M
Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
[TBL] [Abstract][Full Text] [Related]
7. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
8. Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancer.
West H; Albain KS
Semin Oncol; 2005 Jun; 32(3):284-92. PubMed ID: 15988683
[TBL] [Abstract][Full Text] [Related]
9. Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: the Gustave-Roussy experience.
Le Cesne A; Le Chevalier T; Arriagada R
Lung Cancer; 1995 Apr; 12 Suppl 1():S79-85. PubMed ID: 7551937
[TBL] [Abstract][Full Text] [Related]
10. The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.
Gentzler RD; Yentz SE; Johnson ML; Rademaker AW; Patel JD
Cancer; 2014 Dec; 120(24):3853-8. PubMed ID: 25155290
[TBL] [Abstract][Full Text] [Related]
11. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
Langer F; Helsberg K; Schütte WH; Leschinger MI
Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
[TBL] [Abstract][Full Text] [Related]
12. Combined modality treatment of non-small-cell lung cancer.
Westeel V; Depierre A
Am J Respir Med; 2003; 2(6):477-90. PubMed ID: 14719987
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
14. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
[TBL] [Abstract][Full Text] [Related]
16. Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.
De Ruysscher D; Dehing C; Bentzen SM; Houben R; Dekker A; Wanders R; Borger J; Hochstenbag M; Boersma L; Geskes G; Dingemans AM; Bootsma G; Lammering G; Lambin P
Radiother Oncol; 2009 Dec; 93(3):389-95. PubMed ID: 19576645
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy of early stage nonsmall cell lung cancer.
Pisters KM
Respir Care Clin N Am; 2003 Jun; 9(2):191-205. PubMed ID: 12911289
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.
Melosky B; Juergens R; McLeod D; Leighl N; Brade A; Card PB; Chu Q
Lung Cancer; 2019 Aug; 134():259-267. PubMed ID: 31319991
[TBL] [Abstract][Full Text] [Related]
20. Is consolidation chemotherapy after concurrent chemo-radiotherapy beneficial for patients with locally advanced non-small-cell lung cancer? A pooled analysis of the literature.
Tsujino K; Kurata T; Yamamoto S; Kawaguchi T; Kubo A; Isa S; Hasegawa Y; Ou SH; Takada M; Ando M
J Thorac Oncol; 2013 Sep; 8(9):1181-9. PubMed ID: 23883782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
